Alpha 2.0
Login Register
» Articles » PMID: 304761

Membrane Transport of Methotrexate in Human Lymphoblastoid Cells

Overview
Journal Cancer Res
Specialty Oncology
Date 1978 Mar 1
PMID 304761
Citations 6
Authors
R D Warren
A P Nichols
R A Bender
Affiliations
Soon will be listed here.
Citing Articles

Dose adjustment strategy for high-dose methotrexate-induced toxicities in pediatric acute lymphoblastic leukemia: based on population PK analysis and exposure-toxicity relationship.

Cao A, Guan Y, Wang J, Li X, Liu S, Xuan Q Cancer Chemother Pharmacol. 2025; 95(1):33.

PMID: 39954071 DOI: 10.1007/s00280-025-04750-3.

Choroid plexus-CSF-targeted antioxidant therapy protects the brain from toxicity of cancer chemotherapy.

Jang A, Petrova B, Cheong T, Zawadzki M, Jones J, Culhane A Neuron. 2022; 110(20):3288-3301.e8.

PMID: 36070751 PMC: 9588748. DOI: 10.1016/j.neuron.2022.08.009.

The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia.

Oosterom N, Fiocco M, Kloos R, van der Sluis I, Pieters R, van Zelst B BMC Cancer. 2020; 20(1):940.

PMID: 32998716 PMC: 7526241. DOI: 10.1186/s12885-020-07422-y.

Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?.

Lima A, Bernardes M, Azevedo R, Medeiros R, Seabra V Int J Mol Sci. 2015; 16(6):13760-80.

PMID: 26086825 PMC: 4490522. DOI: 10.3390/ijms160613760.

Clinical pharmacokinetics and pharmacology of trimetrexate.

Marshall J, DeLap R Clin Pharmacokinet. 1994; 26(3):190-200.

PMID: 8194282 DOI: 10.2165/00003088-199426030-00003.